Veracyte (NAS:VCYT) Machinery, Furniture, Equipment

: $12.2 Mil (As of Dec. 2022)

View and export this data going back to 2013. Start your Free Trial

Veracyte's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2022 was $12.2 Mil.

Veracyte's quarterly Machinery, Furniture, Equipment stayed the same from Jun. 2022 ($0.0 Mil) to Sep. 2022 ($0.0 Mil) but then increased from Sep. 2022 ($0.0 Mil) to Dec. 2022 ($12.2 Mil).

Veracyte's annual Machinery, Furniture, Equipment increased from Dec. 2020 ($7.1 Mil) to Dec. 2021 ($9.4 Mil) and increased from Dec. 2021 ($9.4 Mil) to Dec. 2022 ($12.2 Mil).

Veracyte Machinery, Furniture, Equipment Historical Data

The historical data trend for Veracyte's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Machinery, Furniture, Equipment

5.50

6.42

7.12

9.44

12.20

Veracyte Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Machinery, Furniture, Equipment																9.44	-	-	-	12.20

Veracyte Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Veracyte (NAS:VCYT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veracyte Inc (NAS:VCYT) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

12V:Germany

Address

6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.veracyte.com

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis product.

Executives

Eliav Barr	director	C/O VERACYTE, INC., 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Jonathan Wygant	officer: VP, Chief Accounting Officer	3750 TORREY VIEW COURT, SAN DIEGO X1 92130
Annie Mcguire	officer: SVP, General Counsel	C/O VERACYTE, INC., 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Rebecca Chambers	officer: Chief Financial Officer	3052 ORCHARD DR., SAN JOSE CA 95134
Jens Holstein	director	C/O VERACYTE, INC., 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Marc Stapley	officer: Chief Executive Officer	9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
Beverly Jane Alley	officer: VP, Corporate Controller	1100 WILSON BOULEVARD, SUITE 3000, ARLINGTON VA 22209
Muna Bhanji	director	C/O CYTOKINETICS, INCORPORATED, 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Erlinger Iii James H	other: EVP, General Counsel	C/O QUINTILES TRANSNATIONAL HOLDINGS INC, 4820 EMPEROR BLVD., DURHAM NC 27703
Hanna John Walter Jr	officer: Chief Commercial Officer	6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Mark Ho	other: Principal Accounting Officer	C/O VERACYTE, INC., 6000 SHORELINE CT, STE 300, SOUTH SAN FRANCISCO CA 94080
Giulia C Kennedy	officer: Chief Scientific & Med Officer	338 MAIN STREET #26E, SAN FRANCISCO CA 94105
Kevin K Gordon	director	155 S LIMERICK RD, LIMERICK PA 19468
Keith Kennedy	officer: Chief Financial Officer	6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Tina Susan Nova	director	C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121